17/05/2026
There has NEVER been a conference like this before. 🔥
For the first time, an emerging therapy for children with PUS3 syndrome will be featured as a topic at an international conference dedicated to gene therapies. ❤️
Our partner, the Gene2Cure Foundation, is organizing a unique event that will bring together scientists, physicians, and families affected by ultra-rare genetic diseases.
Among the speakers will be Professor Leszek Lisowski, PhD, MBA, who is actively involved in developing a gene therapy for children affected by PUS3 syndrome. During the conference, he will present: “How gene therapy works: From vector engineering to clinical delivery.”
We are also honored that Dr. Špela Miroševič, PhD will speak at the conference with her presentation: “Why Gene2Cure exists: Building beyond a single therapy.”
Another featured speaker will be Asst. Prof. Duško Lainšček, PhD, who will present: “PUS3 and GAND syndrome mouse model development and preparing for efficacy studies.”
Just a few years ago, it was hard to imagine that PUS3 syndrome would even enter the world of advanced genetic research. Today, a therapy is actively being developed.
Thank you to everyone who continues to walk this journey with us. ❤️
More information 👉 https://gene2cure.com/gene-therapy-conference-2026/